Tübinger Diabetes Mellitus Database (TUEDID)

Recruiting

• Conditions: Diabetes Mellitus

• Registration Number: NCT03658512
• Lead Sponsor: University Hospital Tuebingen

Brief Summary

Diabetes mellitus is a widespread disease with increasing prevalence worldwide. Patients with diabetes can develop multiple late complications such as neuropathy, retinopathy, nephropathy and cardiovascular comorbidities. So far, there are no reliable predictive tools or markers to estimate if, when and to what extent a patient with diabetes develops late complications. For the patients quality of life and for health economic reasons an improved risk assessment would be desirable. The prospective TUEDID study will characterize diabetic patients to look out for parameters the predict progression of diabetes and its complications.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-08-10
• Study Start: 2018-08-13
• Study First Submitted QC: 2018-08-30
• Study First Posted: 2018-09-05
• Status Verified: 2022-08
• Last Update Submitted: 2022-08-24
• Last Update Posted: 2022-08-29
• Primary Completion: 2028-02-01
• Study Completion: 2028-02-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• >18 years

Exclusion Criteria

• no written informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glycemic control (blood glucose)	At enrolment	Assessed as fasting blood glucose and HbA1C
Glycemic control (HbA1C)	At enrolment	Assessed as fasting HbA1C

Trial Locations

Locations (1)

University of Tuebingen, Internal medicine IV; 🇩🇪 Tuebingen, Germany